Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

BACKGROUND: Preclinical and preliminary clinical data indicate that ch14.18, a monoclonal antibody against the tumor-associated disialoganglioside GD2, has activity against neuroblastoma and that such activity is enhanced when ch14.18 is combined with granulocyte–macrophage colony-stimulating factor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yu, Alice L., Gilman, Andrew L., Ozkaynak, M. Fevzi, London, Wendy B., Kreissman, Susan G., Chen, Helen X., Smith, Malcolm, Anderson, Barry, Villablanca, Judith G., Matthay, Katherine K., Shimada, Hiro, Grupp, Stephan A., Seeger, Robert, Reynolds, C. Patrick, Buxton, Allen, Reisfeld, Ralph A., Gillies, Steven D., Cohn, Susan L., Maris, John M., Sondel, Paul M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3086629/
https://ncbi.nlm.nih.gov/pubmed/20879881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa0911123
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados